| Autor: |
Weber, Thomas Januszewicz, Andrzej Rosei, Enrico Agabiti and Tsioufis, Konstantinos Okorie, Michael Stergiou, George S. and Volpe, Massimo Kreutz, Reinhold Abraham, Gyorgy Azizi, Michel Barna, Istvan Barroso, Weimar Kunz Sebba Brguljan, Jana Chapman, Neil De Backer, Tine Dorobantu, Maria and Eckert, Siegfried Gaciong, Zbigniew Giannattasio, Cristina and Glover, Mark Gottsaeter, Anders Grassos, Charalampos Jarai, Zoltan Aguila, Fernando Jaen Kahan, Thomas Lopez-Sublet, Marilucy Lovic, Dragan Lurbe, Empar Makris, Thomas K. and Mallamaci, Francesca Manolis, Athanasios J. Marketou, Maria and Mazza, Alberto Mediavilla, Juan Diego Muiesan, Maria Lorenza and Muxfeldt, Elizabeth Silaid Nasr, Edgar Papadakis, Ioannis and Parounak, Zelveian Obregon, Sebastian Okorie, Michael and Oliveras, Anna Pontremoli, Roberto Raev, Dimitar Rajkumar, Chakravarthi Redon, Josep Robles, Nicolas Roberto Rump, Lars Christian Sarzani, Riccardo Sierra, Cristina Sirenko, Yuriy and Stojanov, Vesna Tikkanen, Ilkka Vaclavik, Jan Veglio, Franco Viigimaa, Margus Webb, David Zebekakis, Pantelis and Zweiker, Robert European Soc Hypertension Corona-V |
| Jazyk: |
angličtina |
| Rok vydání: |
2021 |
| Popis: |
Background: The Covid-19 pandemic caused a shutdown of healthcare systems in many countries. We explored the impact on hypertension care in the Excellence Center (EC) network of the European Society of Hypertension. Methods: We conducted a 17-question electronic survey among ECs. Results: Overall, 52 ECs from 20 European and three non-European countries participated, providing hypertension service for a median of 1500 hypertensive patients per center per year. Eighty-five percent of the ECs reported a shutdown lasting for 9 weeks (range 0-16). The number of patients treated per week decreased by 90%: from a median of 50 (range 10-400) before the pandemic to a median of 5.0 (range 0-150) during the pandemic (P < 0.0001). 60% of patients (range 0-100%) declared limited access to medical consultations. The majority of ECs (57%) could not provide 24-h ambulatory BP monitoring, whereas a median of 63% (range 0-100%) of the patients were regularly performing home BP monitoring. In the majority (75%) of the ECs, hypertension service returned to normal after the first wave of the pandemic. In 66% of the ECs, the physicians received many questions regarding the use of renin-angiotensin system (RAS) blockers. Stopping RAS-blocker therapy (in a few patients) either by patients or physicians was reported in 27 and 36.5% of the ECs. Conclusion: Patient care in hypertension ECs was compromised during the Covid-19-related shutdown. These data highlight the necessity to develop new strategies for hypertension care including virtual clinics to maintain services during challenging times. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
